Skip to content

A randomised 2x2 trial of community versus hospital rehabilitation, followed by telephone or conventional follow up; impact on quality of life, exercise capacity and use of health care resources

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86821773
Enrollment
240
Registered
2003-04-25
Start date
2002-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease Respiratory Other chronic obstructive pulmonary disease

Interventions

Participants were randomised to one of four groups: 1. Hospital rehabilitation with no telephone follow-up 2. Hospital rehabilitation with telephone follow-up 3. Community rehabilitation with no tele

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Added 04/05/10: 1. Diagnosis of COPD as defined by British Thoracic Society guidelines 2. Medical Research Council (MRC) grade 3 dyspnoea or worse despite optimal care 3. Clinically stable 4 weeks prior to commencing programme 4. Written informed consent

Exclusion criteria

Exclusion criteria: Added 04/05/10: 1. Lack of informed consent 2. Unwilling/lack of motivation to make lifestyle changes 3. Inability to hear and understand educational talks and exercise instructions (hearing aids and interpreters may be used if appropriate) 4. Prognosis under 2 years from any disease 5. Long term oxygen therapy or any requirement for oxygen therapy on exercise 6. Unstable or uncontrolled cardiac disease 7. Musculoskeletal problems precluding exercise training

Design outcomes

Primary

MeasureTime frame
Added 04/05/10: Shuttle walking test (ESWT), assessed post-rehabilitation and at 18 months

Secondary

MeasureTime frame
Added 04/05/10: Health-related quality of life, assessed by Chronic Respiratory Questionnaire (CRQ), Short form-36 (SF-36) and EuroQol (EQ-5D)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 1, 2026